We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$253M
AUM Growth
-$16M
Cap. Flow
+$286M
Cap. Flow %
113.05%
Top 10 Hldgs %
44%
Holding
60
New
10
Increased
18
Reduced
9
Closed
22

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$260M
2
TMO icon
Thermo Fisher Scientific
TMO
+$26M
3
NVO
Novo Nordisk
NVO
+$14.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$11.6M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$8.31M
2
SNY icon
Sanofi
SNY
+$7.53M
3
BSX icon
Boston Scientific
BSX
+$6.54M
4
AMGN icon
Amgen
AMGN
+$6.03M
5
THC icon
Tenet Healthcare
THC
+$5.67M

Sector Composition

Rank Sector Weight
1 Healthcare 98.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
51
IQVIA
IQV
$39.8B
– –
-35,000
Closed -$5.41M
JNJ icon
52
Johnson & Johnson
JNJ
$629B
– –
-35,000
Closed -$5.11M
LH icon
53
Labcorp
LH
$26.2B
– –
-29,100
Closed -$4.23M
MDT icon
54
Medtronic
MDT
$116B
– –
-45,000
Closed -$5.11M
SAGE
55
DELISTED
Sage Therapeutics
SAGE
– –
-15,000
Closed -$1.08M
SNY icon
56
Sanofi
SNY
$105B
– –
-150,000
Closed -$7.53M
SPY icon
57
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
– –
-5,000
Closed -$825K
SRPT icon
58
Sarepta Therapeutics
SRPT
$1.94B
– –
-22,500
Closed -$2.9M
ZTS icon
59
Zoetis
ZTS
$30.4B
– –
-40,000
Closed -$5.29M
SGEN
60
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-19,500
Closed -$2.23M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2020 Portfolio in Review

As of Q1 2020, Sivik Global Healthcare held 60 positions worth $253M, down 5.9% from $269M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sivik Global Healthcare deployed $286M of net new capital in Q1 2020, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Novo Nordisk: 500,000 shares worth $8.16M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $6.54M trimmed.

  • Sivik Global Healthcare's largest Q1 2020 buy was Novo Nordisk: 500,000 shares worth $8.16M.
  • Sivik Global Healthcare added most to Intuitive Surgical in Q1 2020, an estimated $260M increase.
  • Sivik Global Healthcare's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $6.54M.
  • Sivik Global Healthcare fully exited Elevance Health in Q1 2020, selling an estimated $8.31M.
  • Sivik Global Healthcare's ten largest holdings make up 44% of its $253M portfolio in Q1 2020.
  • Sivik Global Healthcare opened 10 new positions and closed 22 in Q1 2020.
  • Sivik Global Healthcare's portfolio value fell 5.9% quarter-over-quarter to $253M.

Based on Sivik Global Healthcare's 13F filing for Q1 2020, filed 15 May 2020.